Incyte Corporation (INCY) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

Earnings Reports

• Incyte (INCY) Q2 2026: Core Business Ex-Jakafi Up 44%, Pipeline and Launches Diversify Growth
  July 28, 2026
• Incyte (INCY) Q4 2025: Core Business Ex-Jakafi Jumps 53% as Pipeline Drives 2026 Inflection
  June 16, 2026
• Insight (INCY) Q1 2026: Core Portfolio Ex-Jakafi Jumps 63%, Accelerating HemOnc & I&I Transition
  April 28, 2026
• Incyte (INCY) Q3 2025: Product Revenue Climbs 19% as Pipeline Pruning Sharpens Focus on Next-Decade Growth
  October 28, 2025
• Incyte (INCY) Q2 2025: Opsalura Surges 35% as Pipeline Execution Drives Guidance Raise
  July 29, 2025
• Incyte (INCY) Q1 2025: JAKAFI Surges 24% as Pipeline Milestones Set Up Multi-Launch Year
  July 06, 2025

Browse all companies